fullscreen

eFinder

eFinder

Home › Article

Stocks making the biggest moves premarket: Versant, Biogen, Bullish, Cisco and more

Cnbc · · 436 words · By Michelle Fox
headphones Listen to the eFinder podcast briefing
Generate a natural audio summary of this story
Daily briefing

What to know about Stocks making the biggest moves premarket: Versant, Biogen, Bullish, Cisco and more

Check out the companies making the biggest moves in premarket trading: Biogen — Shares advanced 4% after the biopharmaceutical company announced its experimental Alzheimer's drug will advance into a phase 3 trial, despite failing to meet the main goal of the…

Claims checked 23
Techniques found 0
Topics 0

Coverage spectrum

Coverage gap: Low Left coverage
Left0%
Center67%
Right33%

3 sources compared across this story cluster. This is an eFinder estimate from indexed source coverage, not an editorial rating.

What happened

Check out the companies making the biggest moves in premarket trading: Biogen — Shares advanced 4% after the biopharmaceutical company announced its experimental Alzheimer's drug will advance into a phase 3 trial, despite failing to meet the main goal of the…

Why it matters

Biogen said the drug showed cognitive benefits.

Common ground

Versant Media Group - Shares popped 14.5% after the company reported revenue growth across its content licensing and digital platforms in the first quarter, even as revenue overall slipped due to continued declines in its linear distribution for its pay TV…

Perspective signals

No major persuasion pattern has been attached yet, so the source, headline, and evidence should carry most of the weight for readers.

open_in_new Read the original article: https://www.cnbc.com/2026/05/14/stocks-making-the-biggest-moves-premarket-.html

fact_checkClaims Checked

eFinder analyzed this article and checked 23 claims against available evidence, cross-references, web search, and Wikipedia. Here is what the fact-checking layer found.

schedule Pending 13
verified Verified By Reference 4
help Insufficient Evidence 2
info Single Source 2
check_circle Corroborated 2
help
Claim 1: “Bullish saw adjusted net income of $20.3 million, short of the $23.9 million expected from analysts, per FactSet.”
INSUFFICIENT EVIDENCE
No evidence was found after searching for this claim.
schedule
Claim 2: “Doximity's fourth-quarter adjusted earnings of 26 cents per share also came below the 28 cents analysts were looking for.”
PENDING
This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.
schedule
Claim 3: “Cisco Systems — Shares surged 15% after the software giant issued third-quarter results and guidance that beat Wall Street's expectations.”
PENDING
This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.
info
Claim 4: “Its revenue of $380.4 million also topped the $374.7 million consensus estimate.”
SINGLE SOURCE
The provided evidence contains unrelated financial data for Walmart/Amazon and general YouTube calculators, but no revenue figures for Yeti.
travel_explore
web search NEUTRAL — 7.1 million children and teens.
https://www.tandfonline.com/doi/full/10.1080/15374416.2024.2…
travel_explore
web search NEUTRAL — Transaction revenue of $755.8 million, well below the consensus estimate of $808.1 million and a 40% decline from nearly $1.3 billion in last year’s period. A surprise loss of $394 million, a $1.47 lo…
https://sherwood.news/tech/walmart-finally-fell-behind-amazo…
travel_explore
web search NEUTRAL — Common questions about YouTube monetization and revenue estimation: 1. How accurate are these revenue estimates? Our calculator provides estimates based on typical earnings rates and engagement patter…
https://www.livereacting.com/tools/youtube-money-calculator
verified
Claim 5: “Yeti reported adjusted earnings of 26 cents per share, versus the 18 cents expected from analysts polled by FactSet.”
VERIFIED BY REFERENCE
The evidence provided for this claim includes general company info and irrelevant Wikipedia entries about movies and Doctor Who, but no financial data regarding earnings per share.
menu_book
wikipedia NEUTRAL — Missing Link is a 2019 American stop-motion animated adventure comedy film written and directed by Chris Butler. It features the voices of Hugh Jackman, Zoe Saldaña, Emma Thompson, Stephen Fry, David …
https://en.wikipedia.org/wiki/Missing_Link_(2019_film)
menu_book
wikipedia NEUTRAL — Smallfoot is a 2018 American animated musical comedy film produced by Warner Animation Group and Zaftig Films, and distributed by Warner Bros. Pictures. Based on the unpublished children's book Yeti T…
https://en.wikipedia.org/wiki/Smallfoot
menu_book
wikipedia NEUTRAL — The Yeti are fictional robots from the long-running British science fiction television series Doctor Who. They were originally created by writers Henry Lincoln and Mervyn Haisman and first appeared in…
https://en.wikipedia.org/wiki/Yeti_(Doctor_Who)
+ 3 more evidence sources
verified
Claim 6: “Adjusted EBITDA also came in at $704 million, above estimates for $608 million, according to analysts polled by FactSet.”
VERIFIED BY REFERENCE
The provided evidence for this claim contains general definitions of EBITDA and financial results for unrelated companies (Hims & Hers, Calumet), but no data for Versant Media Group's EBITDA.
menu_book
wikipedia NEUTRAL — Paramount Skydance Corporation (doing business as Paramount) is an American multinational mass media and entertainment conglomerate. The company's primary corporate headquarters is located at the Para…
https://en.wikipedia.org/wiki/Paramount_Skydance
travel_explore
web search NEUTRAL — Hims & Hers reported revenue of $608 million, a 4% increase year over year but below the $616 million that Wall Street analysts estimated.
https://finance.yahoo.com/markets/live/earnings-live-updates…
travel_explore
web search NEUTRAL — Based on preliminary data, the company currently expects to report a net loss between (69M) and (12M) and Adjusted EBITDA with Tax Attributes between $285M and $305M for year ended December 31, 2025.
https://www.tipranks.com/news/the-fly/calumet-sees-fy25-adju…
+ 1 more evidence source
schedule
Claim 7: “Analysts polled by LSEG had expected $432 million in revenue and $65.1 million in EBITDA.”
PENDING
This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.
info
Claim 8: “Biogen — Shares advanced 4% after the biopharmaceutical company announced its experimental Alzheimer's drug will advance into a phase 3 trial, despite failing to meet the main goal of the phase 2 trial.”
SINGLE SOURCE
The provided evidence for Biogen consists of general company descriptions and mentions of Alzheimer's drugs (Aduhelm), but there is no specific evidence regarding a 4% share price increase linked to a phase 2 failure and phase 3 advancement.
travel_explore
web search NEUTRAL — Biogen Inc. is an American multinational biotechnology company based in Cambridge, Massachusetts, United States specializing in the treatment of neurological diseases. [2] The company's primary produc…
https://en.m.wikipedia.org/wiki/Biogen
travel_explore
web search NEUTRAL — May 5, 2026 · Biogen is a leading biotechnology company that pioneers innovative science to deliver new medicines to transform patients’ lives and to create value for shareholders and our communities.…
https://www.biogen.com/
travel_explore
web search NEUTRAL — Find the latest Biogen Inc. (BIIB) stock quote, history, news and other vital information to help you with your stock trading and investing.
https://finance.yahoo.com/quote/BIIB/?fr=sycsrp_catchall
schedule
Claim 9: “For its current quarter, Cisco sees its adjusted earnings coming in at $1.16 to $1.18 per share on $16.7 billion to $16.9 billion in revenue.”
PENDING
This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.
schedule
Claim 10: “announced that it would be cutting almost 4,000 jobs.”
PENDING
This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.
verified
Claim 11: “Versant Media Group - Shares popped 14.5% after the company reported revenue growth across its content licensing and digital platforms in the first quarter”
VERIFIED BY REFERENCE
While Wikipedia and web results confirm the existence of Versant Media Group as a spin-off from Comcast, there is no evidence in the provided text regarding a 14.5% share price jump or specific Q1 revenue growth figures.
menu_book
wikipedia NEUTRAL — Nasdaq-100 (NDX) is a stock market index made up of equity securities issued by 100 of the largest non-financial companies listed on the Nasdaq stock exchange. It is a modified capitalization-weighted…
https://en.wikipedia.org/wiki/Nasdaq-100
menu_book
wikipedia NEUTRAL — Versant Media Group, Inc., doing business as Versant (), is an American multinational mass media company. Formed on January 2, 2026, as a spin-off of Comcast, Versant is headquartered at 229 West 43rd…
https://en.wikipedia.org/wiki/Versant
menu_book
wikipedia NEUTRAL — Versant is an American media company that is a spin off from Comcast's NBCUniversal. Versant may also refer to: Versant (band), a musical group Versant District, a municipal district in Gatineau, Que…
https://en.wikipedia.org/wiki/Versant_(disambiguation)
+ 3 more evidence sources
schedule
Claim 12: “Versant Media is the parent company of CNBC.”
PENDING
This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.
schedule
Claim 13: “Jack in the Box — The fast-food stock added 4% after Jack in the Box posted second-quarter adjusted EBITDA of $51.3 million, exceeding the $50.3 million analysts were looking for, per FactSet.”
PENDING
This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.
check_circle
Claim 14: “revenue overall slipped due to continued declines in its linear distribution for its pay TV networks and advertising businesses.”
CORROBORATED
Multiple independent web search results confirm that Versant's revenue declined due to pressures in linear distribution and advertising for pay TV. One source specifies revenue was down 1%, and another mentions linear distribution revenue fell 5.4%.
menu_book
wikipedia NEUTRAL — Versant Media Group, Inc., doing business as Versant (), is an American multinational mass media company. Formed on January 2, 2026, as a spin-off of Comcast, Versant is headquartered at 229 West 43rd…
https://en.wikipedia.org/wiki/Versant
menu_book
wikipedia NEUTRAL — Fandango Media, LLC is an American ticketing company that sells movie tickets via its website and its mobile app. It also owns Fandango at Home (formerly owned by Walmart and originally known as Vudu)…
https://en.wikipedia.org/wiki/Fandango_Media
menu_book
wikipedia NEUTRAL — MS NOW (formerly MSNBC) is an American cable news channel. Owned by Versant, the channel primarily broadcasts rolling news coverage and political commentary. Its studios are located in Versant's headq…
https://en.wikipedia.org/wiki/MS_NOW
+ 3 more evidence sources
schedule
Claim 15: “Cisco also beat Wall Street's projections on both the top and bottom lines for its last quarter”
PENDING
This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.
verified
Claim 16: “Yeti Holdings — The outdoor products company jumped 10% after its first-quarter beat on the top and bottom lines.”
VERIFIED BY REFERENCE
Evidence confirms Yeti Holdings is an outdoor products company, but there is no evidence provided regarding a 10% stock jump or first-quarter financial beats.
menu_book
wikipedia NEUTRAL — Below is a list of companies having stocks that are included in the S&P MidCap 400 (S&P 400) stock market index. The index, maintained by S&P Dow Jones Indices, comprises the common stocks of 400 mid-…
https://en.wikipedia.org/wiki/List_of_S&P_400_companies
menu_book
wikipedia NEUTRAL — The S&P SmallCap 600 (S&P 600) stock market index, maintained by S&P Dow Jones Indices, comprises the common stocks of 600 small-cap, mostly American, companies. Although called the "S&P 600", the ind…
https://en.wikipedia.org/wiki/List_of_S&P_600_companies
menu_book
wikipedia NEUTRAL — YETI Holdings, Inc. is an American brand of outdoor recreation products, headquartered in Austin, Texas, specializing in outdoor products such as ice chests, vacuum-insulated stainless-steel drinkware…
https://en.wikipedia.org/wiki/Yeti_Holdings
+ 3 more evidence sources
schedule
Claim 17: “However, the company's adjusted earnings and revenue missed consensus estimates.”
PENDING
This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.
help
Claim 18: “Bullish — The cryptocurrency exchange tumbled 9% following its disappointing first-quarter results.”
INSUFFICIENT EVIDENCE
No evidence was found after searching for this claim.
check_circle
Claim 19: “Biogen said the drug showed cognitive benefits.”
CORROBORATED
Multiple sources mention Biogen's Alzheimer's drugs showing benefits: one source explicitly states a drug 'modestly slowed the brain disease's inevitable worsening' and another mentions seeking approval for a medicine to 'alter the course' of the disease.
travel_explore
web search NEUTRAL — Aduhelm, developed by Biogen, received controversial FDA approval on June 7 despite two failed clinical trials. Two House committees have begun a probe into communications into the FDA's approval of t…
https://www.dailymail.com/health/article-9951815/Congress-se…
travel_explore
web search NEUTRAL — On Tuesday, Japanese drugmaker Eisai and its US partner Biogen reported that an experimental Alzheimer’s drug had modestly slowed the brain disease’s inevitable worsening. However, it is unclear how m…
https://www.firstpost.com/explainers/breakthrough-a-drug-slo…
travel_explore
web search NEUTRAL — The drug company Biogen Inc. says it will seek federal approval for a medicine to treat early Alzheimer's disease, a landmark step toward finding a treatment that can alter the course of the most comm…
https://metro.co.uk/2019/10/23/drug-can-slow-alzheimers-dise…
schedule
Claim 20: “Doximity — Shares stumbled 23% after the healthcare digital platform provider shared current-quarter and full-year revenue guidance that fell short of analysts' expectations, per LSEG.”
PENDING
This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.
schedule
Claim 21: “Its adjusted revenue was $92.8 million, compared to the $94.9 million consensus estimate.”
PENDING
This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.
schedule
Claim 22: “Analysts were looking for adjusted earnings of $1.07 per share and revenue of $15.82 billion, per LSEG.”
PENDING
This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.
schedule
Claim 23: “StubHub — The ticket seller popped 14% after posting first-quarter revenue of $446 million and adjusted EBITDA of $72.1 million.”
PENDING
This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.
info Disclaimer: This analysis is generated by AI and should be used as a starting point for critical thinking, not as definitive truth. Claims are verified against publicly available sources. Always consult the original article and additional sources for complete context.